Trexquant Investment LP Adverum Biotechnologies, Inc. Transaction History

Trexquant Investment LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$9.26 - $14.36 $109,971 - $170,539	-11,876 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$9.84 - $14.26 $116,859 - $169,351	11,876 New	11,876 $129,000
Q2 2018 Aug 07, 2018	SELL	$5.3 - $6.9 $167,713 - $218,343	-31,644 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$3.65 - $7.95 $115,500 - $251,569	31,644 New	31,644 $184,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $681M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.